. VEGF-A stimulates VEC-Y658 phosphorylation in heart tissues and HUVEC cells. (A) Progeny from FAK fl/fl stem cell leukemia locus (SCL)-Cre-ER(T) and heterozygous FAK KD/WT crosses are treated with tamoxifen to induce Cre activation creating mice with hemizygous FAK-WT or FAK-KD expression in ECs. (B) Schematic of in vivo signaling assay using VEGF-A tail vein injection and rapid isolation of lung tissue. (C) Heart protein lysates from FAK-WT or FAK-KD mice tail vein injected with PBS or VEGF-A (0.2 mg/kg) were made within 2 min. Lysates were evaluated by VEGFR-2 immunoprecipitations (IP), phosphotyrosine (pY), and VEGFR-2 blotting. Lysates were analyzed by VEC pY658, FAK pY397, and c-Src pY416 phosphospecific immunoblotting and reprobed for total VEC, FAK, or c-Src. Actin was used as a loading control. (D) Confluent starved HUVECs were stimulated with 50 ng/ml VEGF-A for the indicated times, and lysates were analyzed for pY658 VEC, pY142 -catenin, and pY397 FAK and then reprobed for total VEC, FAK, and c-Src. (E) Confluent starved HUVECs were pretreated or not treated with 1 µM PF-271 (60 min) and then stimulated with 10 ng/ml TNF for the indicated times. Lysates were analyzed for pY658 VEC, VEC, and actin by immunoblotting. 
